Sector ratings Evotec SE

Equities

Market Closed - Xetra Other stock markets 09:11:03 06/09/2024 pm IST			5-day change	1st Jan Change
5.940 ^EUR	-2.14%		-11.01%	-72.09%

05/09	Evotec, X-Chem to Collaborate on Early-Stage Drug Discovery	MT
05/09	Evotec SE and X-Chem Inc. Collaborates to Accelerate Early-Stage Drug Discovery	CI

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Composite Valuation	ESG Refinitiv	Capi. ($)
EVOTEC SE	-	A-	116.94Cr
LONZA GROUP AG		A	4.6TCr
IQVIA HOLDINGS INC.		B	4.43TCr
ALNYLAM PHARMACEUTICALS, INC.	-	B	3.17TCr
CELLTRION, INC.		C	2.96TCr
MODERNA, INC.	-	B-	2.8TCr
ICON PUBLIC LIMITED COMPANY		B-	2.51TCr
UNITED THERAPEUTICS CORPORATION		B+	1.54TCr
BIO-TECHNE CORPORATION		B+	1.13TCr
MEDPACE HOLDINGS, INC.		C+	1.04TCr
QIAGEN N.V.		A	988.54Cr
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.		C+	970.45Cr
REVOLUTION MEDICINES, INC.	-	C-	698.89Cr
IONIS PHARMACEUTICALS, INC.	-	B+	685.58Cr
BACHEM HOLDING AG		B-	669.59Cr
HANGZHOU TIGERMED CONSULTING CO., LTD		B+	551.22Cr
BLUEPRINT MEDICINES CORPORATION		B-	547.49Cr
Average		B	1.73TCr
Weighted average by Cap.		B